US Infant Formula Supply Regulation Overhaul Extends To Guidance On Reporting Disruptions

Formula manufacturers must notify FDA of permanent discontinuance or interruption in production “likely to lead to a meaningful disruption in the supply … and the reasons for such discontinuance or interruption” no later than five business days after a problem is identified.